FUKUSHIMA JOURNAL OF MEDICAL SCIENCE
Online ISSN : 2185-4610
Print ISSN : 0016-2590
ISSN-L : 0016-2590

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Short-term Outcomes of Robotic Lateral Pelvic Lymph Node Dissection for Lower Rectal Cancer
Wataru SakamotoSatoshi FukaiTakahiro SatoMisato ItoTakuro MatsumotoMai AshizawaShun ChidaHisashi OnozawaHirokazu OkayamaHisahito EndoMotonobu SaitoZenichiro SazeTomoyuki MommaKoji Kono
著者情報
ジャーナル オープンアクセス HTML 早期公開

論文ID: 24-00039

この記事には本公開記事があります。
詳細
抄録

Introduction: Rectal cancer is among the main causes of cancer-related mortalities worldwide, necessitating more effective treatment strategies. It is considered that lateral pelvic lymph node dissection (LPND) for rectal cancer patients can contribute to local tumor control and that robotic LPND (Rob-LPND) may be more suitable for LPND, due to technical advantages of precise manipulation in a narrow pelvic space.

Methods: In this retrospective study, we evaluated the short-term outcomes of laparoscopic-LPND (Lap-LPND) versus Rob-LPND in patients undergoing radical surgery for rectal cancer. Operative time, blood loss, urethral catheter reinsertion, duration of pelvic drainage tube placement, drainage volume, and postoperative hospital stay were compared between Lap-LPND and Rob-LPND.

Results: Our findings revealed that Rob-LPND was associated with longer total operation time, but there was no significant difference in operation time between the two LPND techniques. Urinary catheter re-insertion rates were lower in Rob-LPND; also, significant reductions in drainage tube duration, total drainage volume, and postoperative hospital stay were observed.

Conclusion: Rob-LPND may reduce postoperative total drainage volume and shorten postoperative hospital stays. These improvement in short-term outcomes suggest potential clinical advantages of Rob-LPND.

著者関連情報
© 2025 The Fukushima Society of Medical Science

This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
https://creativecommons.org/licenses/by-nc-sa/4.0/
feedback
Top